Veteran Actor Luo Jiaying Faces Cancer Recurrence with Unwavering Optimism
Fighting Three Cancers, Actor Opts for Hormone Therapy Over Chemotherapy
Hong Kong actor Luo Jiaying, beloved for his roles in iconic films like “Domestic Ling Ling Paint” and “A Chinese Odyssey,” is confronting a renewed battle with cancer. Having previously overcome liver cancer twice and prostate cancer, the 79-year-old star recently revealed his prostate cancer has returned.
A Unique Approach to Extended Life
Despite the challenging diagnosis, Luo Jiaying remains remarkably positive. He shared in a recent interview that he is currently undergoing treatment with female hormones. This approach aims to slow the spread of cancer cells by reducing male hormone levels.
“I have at most eight or nine years of lifespan.”
—Luo Jiaying
The veteran performer stated that while he anticipates needing chemotherapy in the future, he has decided against it, expressing a peaceful acceptance of his mortality.
Spousal Support and a Resilient Spirit
Luo Jiaying‘s wife, actress Liza Wang, addressed her husband’s condition for the first time, offering a reassuring perspective.
“This is a very common thing! The condition is developing very slowly, and there will be many new drugs in the future. I respect his decision.”
—Liza Wang
Liza Wang emphasized her optimistic outlook and support for her husband’s choices as he navigates his health challenges.
On Stage Despite Adversity
Even while managing his health, Luo Jiaying continues to engage with his art. He recently made a memorable appearance at a concert by Karen Mok in Xi’an, China. The duo performed their classic song “Only You,” delighting fans and evoking fond memories of their collaboration on “A Chinese Odyssey” over three decades ago.
Statistics show that advancements in cancer treatment continue to improve outcomes. For instance, the overall cancer survival rate in the United States has increased significantly over the past few decades, reflecting progress in diagnosis and therapy. According to the American Cancer Society, the 5-year relative survival rate for all cancers combined increased by more than 20% between the mid-1970s and 2015 (American Cancer Society, 2024).
